New-build residential market monitoring (2)
- Reference: 2024/3946
- Question by: Zoë Garbett
- Meeting date: 21 November 2024
New-build residential market monitoring
- Reference: 2024/3945
- Question by: Zoë Garbett
- Meeting date: 21 November 2024
Opportunity Area designation
- Reference: 2024/3944
- Question by: Zoë Garbett
- Meeting date: 21 November 2024
Opportunity Area monitoring
- Reference: 2024/3943
- Question by: Zoë Garbett
- Meeting date: 21 November 2024
Cannabis decriminalisation (2)
- Reference: 2024/3942
- Question by: Zoë Garbett
- Meeting date: 21 November 2024
Drug deaths and coroners
- Reference: 2024/3941
- Question by: Zoë Garbett
- Meeting date: 21 November 2024
Pre-arrest drug diversion (2)
- Reference: 2024/3940
- Question by: Zoë Garbett
- Meeting date: 21 November 2024
MPS drugs strategy
- Reference: 2024/3939
- Question by: Zoë Garbett
- Meeting date: 21 November 2024
London Race Action Plan traffic stops
- Reference: 2024/3938
- Question by: Zoë Garbett
- Meeting date: 21 November 2024
London Race Action Plan community reference group
- Reference: 2024/3937
- Question by: Zoë Garbett
- Meeting date: 21 November 2024